相关实验视频

Updated: Jul 16, 2025

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

"海湾战争病"是一个长期的早期阶段的病吗?

Peter W Baas¹, Kimberly A Sullivan², Alvin V Terry³

¹Department of Neurobiology and Anatomy, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.

Cytoskeleton (Hoboken, N.J.)

|September 13, 2023

概括

海湾战争疾病 (GWI) 退伍军人表现出轻微的认知障碍,与大脑度升高有关. 早期检测和干预对于预防痴呆和其他神经退行性疾病的进展至关重要.

科学领域:

神经科学是一个神经科学.
环境健康环境健康
退伍军人事务退伍军人事务

背景情况:

海湾战争疾病 (GWI) 与认知能力下降有关,特别是记忆问题.
这些认知缺陷不符合痴呆症标准,但引发了对未来进展的担忧.

研究的目的:

调查大脑中高水平作为GWI认知问题的原因的潜在作用.
探索GWI退伍军人的血液中的tau自身抗体作为生物标志物.
确定GWI认知障碍的紧急治疗和预防策略.

主要方法:

利用人类大脑器官和老鼠模型来研究GWI.
在GWI退伍军人中分析了tau自身抗体的血液样本.

主要成果:

最近的研究表明,大脑中的升高可能是GWI认知问题的基础.
在GWI退伍军人的血液中发现了高水平的tau自身抗体.

结论:

升的可能是GWI相关认知障碍的关键因素.
GWI认知状态可能代表病的早期阶段,这种情况在神经退行性疾病中很常见.
对于GWI退伍军人来说,迫切需要开发治疗和预防策略.

关键词:

墨西哥湾战争疾病反感的寡核化物.微管是微管中的一个.知道了,就知道了.病症是一种病症.

更多相关视频

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice

Published on: March 11, 2020

相关概念视频

Long-term Potentiation

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...